Christopher Blazes, M.D.

  • Assistant Professor of Psychiatry, School of Medicine
  • Assistant Professor of Emergency Medicine, School of Medicine


Dr. Blazes is triple board-certified in psychiatry, addiction psychiatry, and emergency medicine and is the director of the OHSU addiction psychiatry Fellowship. He is a clinician educator whose practice is based out of the Portland VA Medical Center. He lectures widely and publishes on such topics as benzodiazepines, synthetic fentanyl analogues, buprenorphine, and the neurobiology of addiction and recovery.

Education and training

    • M.D., 1997, University of Rochester
  • Residency

    • Emergency Medicine, Brown University, Providence, RI, 2001
    • Psychiatry, Albert Einstein College of Medicine, New York, NY, 1997
  • Fellowship

    • Addiction Psychiatry, University of California San Francisco, 1998
  • Certifications

    • American Board of Psychiatry and Neurology (Psychiatry)
    • American Board of Psychiatry and Neurology (Addiction Psychiatry)
    • American Board of Emergency Medicine

Areas of interest

  • Benzodiazepines, acute and post-acute withdrawal
  • Strategies for de-prescribing
  • The neurobiology of Addiction and Recovery
  • Residential and long term treatment facilities


Selected publications

  • Reconsidering the Usefulness of adding Naloxone to Buprenorphine, Christopher  Blazes, Jonathan Morrow. Front. Psychiatry, 11 September 2020 |
  • Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges. Joan E Zweben 1, James L Sorensen, Mallory Shingle, Christopher K Blazes. J Addict Med 2020 Dec 15; Publish Ahead of Print. doi: 10.1097/ADM.0000000000000789.


  • {{[0].value }}